Niagen Bioscience, Inc. (NAGE)
NASDAQ: NAGE · Real-Time Price · USD
4.480
-0.120 (-2.61%)
At close: Apr 9, 2026, 4:00 PM EDT
4.630
+0.150 (3.35%)
After-hours: Apr 9, 2026, 7:59 PM EDT

Niagen Bioscience Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
360507411107125255
Market Cap Growth
-39.16%23.47%282.96%-14.41%-50.83%-14.22%
Enterprise Value
298.09444.01367.6282.47108.39230.73
Last Close Price
4.486.365.311.431.683.74
PE Ratio
22.4031.8048.27-20.43-7.00-9.35
Forward PE
16.8427.8150.28---
PS Ratio
2.783.924.121.281.743.78
PB Ratio
4.806.628.913.774.378.03
P/TBV Ratio
4.987.109.003.774.097.92
P/FCF Ratio
27.2438.3734.3715.39-8.12-10.37
P/OCF Ratio
26.6537.5433.9115.07-8.30-10.54
EV/Sales Ratio
2.303.433.690.991.503.42
EV/EBITDA Ratio
19.7733.9043.05-18.04-6.17-8.89
EV/EBIT Ratio
20.8536.0647.58-14.73-5.82-8.52
EV/FCF Ratio
22.5633.6130.7711.83-7.02-9.39
Debt / Equity Ratio
0.020.020.040.090.120.13
Debt / EBITDA Ratio
0.220.220.31-0.72-0.24-0.18
Debt / FCF Ratio
0.210.210.220.47-0.28-0.19
Net Debt / Equity Ratio
-0.81-0.81-0.91-0.84-0.56-0.74
Net Debt / EBITDA Ratio
-4.73-4.73-4.925.260.920.91
Net Debt / FCF Ratio
-4.69-4.69-3.52-3.451.050.96
Asset Turnover
1.481.481.621.531.291.40
Inventory Turnover
3.123.123.212.252.072.05
Quick Ratio
3.743.742.921.581.621.90
Current Ratio
4.864.863.572.402.612.78
Return on Equity (ROE)
22.43%25.00%22.94%-17.29%-54.77%-112.68%
Return on Assets (ROA)
13.31%13.39%12.11%-10.27%-33.29%-56.29%
Return on Invested Capital (ROIC)
76.56%77.00%98.23%-45.68%-127.08%-288.01%
Return on Capital Employed (ROCE)
18.00%18.00%18.25%-15.88%-48.75%-87.18%
Earnings Yield
4.83%3.14%2.07%-4.90%-14.29%-10.70%
FCF Yield
3.67%2.61%2.91%6.50%-12.32%-9.64%
Buyback Yield / Dilution
-9.36%-9.36%-4.19%-7.54%-3.79%-10.02%
Total Shareholder Return
-9.36%-9.36%-4.19%-7.54%-3.79%-10.02%
Updated Mar 4, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q